PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 8, 2025Biomolecules5 citationsOpen Access

The Relationship Between NETosis and Biofilm Formation in Chronic Infections

View Full Paper
VKVinay KumarATAnuradha Tyagi

Key Points

  • Chronic infections relate to biofilm formation, with significant implications for treatment approaches.
  • The review outlines molecular mechanisms linking NETs and pathogens in cystic fibrosis lung disease and diabetic foot ulcers.
  • Assessment of therapeutic strategies includes DNase-based treatments to combat biofilm stability and immune evasion.
  • Understanding the role of neutrophil extracellular traps may enable more effective management of chronic infections.

Abstract

Chronic infections pose significant clinical challenges due to their persistent nature, heightened resistance to conventional therapies, and association with biofilm formation. Neutrophil extracellular traps (NETs), released through a unique form of cell death known as NETosis, serve as an innate immune defense mechanism by trapping and neutralizing pathogens. However, accumulating evidence reveals a complex and paradoxical relationship between NETs and microbial biofilms. While NETs can immobilize and kill planktonic microbes, the extracellular DNA and associated proteins often contribute to biofilm stability, immune evasion, and chronic infection persistence. This review explores the bidirectional interactions between NETosis and biofilm formation, with a focus on their synergistic roles in the pathogenesis of chronic infections such as cystic fibrosis lung disease, diabetic foot ulcers, periodontitis, and implant-associated infections. We outline the molecular mechanisms governing NETosis, the structural and functional dynamics of biofilms, and how these processes intersect to form recalcitrant infection niches. Emerging therapeutic strategies aimed at disrupting this pathogenic interplay including DNase-based treatments, PAD4 inhibitors, and combination therapies are critically evaluated. By illuminating the pathogenic synergy between NETs and biofilms, this review underscores the need for integrated immunomodulatory and anti-biofilm interventions to effectively manage chronic infectious diseases and improve patient outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kumar et al. (2025) studied this question.

synapsesocial.com/papers/693624c34fa91c937236caachttps://doi.org/10.3390/biom15121692
Ask AI
Helpful
Bookmark
Share
View Full Paper